Shirley V Wang

Shirley V Wang

Harvard University - Cambridge / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1388740
person_outline Shirley V Wang's MOST POPULAR ARTICLES
1-) Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in …ML Berger, H Sox, RJ Willke, DL Brixner, HG Eichler, W Goettsch, ...Pharmacoepidemiology and Drug Safety 26 (9), 1033-1039, 20174072017
2-) Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1. 0SV Wang, S Schneeweiss, ML Berger, J Brown, F Vries, I Douglas, ...Pharmacoepidemiology and drug safety 26 (9), 1018-1032, 20171662017
3-) Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.SV Wang, P Verpillat, JA Rassen, A Patrick, EM Garry, DB BartelsClinical Pharmacology & Therapeutics 99 (3), 325-332, 20161412016
4-) Future-cases as present controls to adjust for exposure-trend bias in case-only studiesS Wang, C Linkletter, M Maclure, D Dore, V Mor, S Buka, GA WelleniusEpidemiology (Cambridge, Mass.) 22 (4), 568, 2011902011
5-) Estimation using all available covariate information versus a fixed look‐back window for dichotomous covariatesSM Brunelli, JJ Gagne, KF Huybrechts, SV Wang, AR Patrick, KJ Rothman, ...Pharmacoepidemiology and drug safety 22 (5), 542-550, 2013892013